BAKER HEART AND DIABETES INSTITUTE

Australian-made drug Hi1a, derived from K'gari funnel-web spider venom, aims to revolutionize heart attack and stroke treatment, protect donor hearts, and improve survival rates. Funded by $17.8 million from the Medical Research Future Fund, clinical trials are set to begin within the year.